| __timestamp | Agios Pharmaceuticals, Inc. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 94103000 |
| Thursday, January 1, 2015 | 141827000 | 146194000 |
| Friday, January 1, 2016 | 220163000 | 130000 |
| Sunday, January 1, 2017 | 292681000 | 7353000 |
| Monday, January 1, 2018 | 1397000 | 34193000 |
| Tuesday, January 1, 2019 | 1317000 | 56586000 |
| Wednesday, January 1, 2020 | 2805000 | 63382000 |
| Friday, January 1, 2021 | 18777000 | 97049000 |
| Saturday, January 1, 2022 | 1704000 | 139989000 |
| Sunday, January 1, 2023 | 9504000 | 150343000 |
| Monday, January 1, 2024 | 4165000 |
Data in motion
In the dynamic world of biotechnology, understanding cost structures is crucial for investors and stakeholders. This analysis delves into the cost of revenue trends for Sarepta Therapeutics, Inc. and Agios Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Sarepta Therapeutics has shown a consistent increase in its cost of revenue, peaking in 2023 with a 60% rise compared to 2014. This reflects the company's expanding operations and investment in research and development. In contrast, Agios Pharmaceuticals experienced a significant fluctuation, with a notable spike in 2017, followed by a dramatic reduction in subsequent years. By 2023, Agios's cost of revenue had decreased by approximately 90% from its 2017 peak, indicating strategic shifts or operational efficiencies. These insights highlight the contrasting financial strategies and market responses of these two biotech giants.
Cost Insights: Breaking Down Novartis AG and Agios Pharmaceuticals, Inc.'s Expenses
Regeneron Pharmaceuticals, Inc. vs Sarepta Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Sarepta Therapeutics, Inc.
Cost of Revenue Trends: Dr. Reddy's Laboratories Limited vs Agios Pharmaceuticals, Inc.
Cost of Revenue Comparison: Bio-Techne Corporation vs Sarepta Therapeutics, Inc.
Analyzing Cost of Revenue: Sarepta Therapeutics, Inc. and Travere Therapeutics, Inc.
Sarepta Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Agios Pharmaceuticals, Inc.
Alkermes plc vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Ligand Pharmaceuticals Incorporated vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Agios Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.